Alnylam Pharmaceuticals, Inc. logo

ALNY

Alnylam Pharmaceuticals, Inc.

$148.5

Earnings Summary

Revenue
$439.72Mn
Net Profits
$-137.87Mn
Net Profit Margins
-31.35%

Highlights

Revenue:

Alnylam Pharmaceuticals, Inc.’s revenue jumped 31.25% since last year same period to $439.72Mn in the Q4 2023. On a quarterly growth basis, Alnylam Pharmaceuticals, Inc. has generated -41.41% fall in its revenue since last 3-months.

Net Profits:

Alnylam Pharmaceuticals, Inc.’s net profit jumped 33.55% since last year same period to $-137.87Mn in the Q4 2023. On a quarterly growth basis, Alnylam Pharmaceuticals, Inc. has generated -193.31% fall in its net profits since last 3-months.

Net Profit Margins:

Alnylam Pharmaceuticals, Inc.’s net profit margin jumped 49.37% since last year same period to -31.35% in the Q4 2023. On a quarterly growth basis, Alnylam Pharmaceuticals, Inc. has generated -259.27% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Alnylam Pharmaceuticals, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-1.18
EPS Estimate Current Year
-1.18

Highlights

EPS Estimate Current Quarter:

Alnylam Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.18 - a 10.61% jump from last quarter’s estimates.

EPS Estimate Current Year:

Alnylam Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.18.

Key Ratios

Key ratios of the Alnylam Pharmaceuticals, Inc. post its Q4 2023 earnings

Earning Per Share (EPS)
-1.1

Highlights

Earning Per Share (EPS):

Alnylam Pharmaceuticals, Inc.’s earning per share (EPS) jumped 34.52% since last year same period to -1.1 in the Q4 2023. This indicates that the Alnylam Pharmaceuticals, Inc. has generated 34.52% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-02-15
-1.32
-1.1
16.67%
2023-05-04
-1.77
-1.4
20.9%
2023-11-02
-1.34
1.15
185.82%
2023-08-03
-1.37
-2.21
-61.31%